Results 221 to 230 of about 25,961,939 (368)

Optimal Covering of a Straight Line Applied to Discrete Convexity [PDF]

, 2013
Jean‐Marc Chassery, Isabelle Sivignon
openalex   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Association Between Taste Disorders and Malnutrition in Older Adults: A Scoping Review. [PDF]

Nutr Rev
Bauer S, Blanar V, Pospichal J, Eglseer D, Chrastecka M.   +4 more
europepmc   +1 more source

COMPARATIVE BIOLOGICAL AND BIOCHEMICAL ASSESSMENT FOR TOXICOLOGICAL PROFILE OF SOME ECO-FRIENDLY INSECTICIDES APPLIED FOR CONTROLLING OF THE FOURTH INSTAR LARVAE OF SPODOPTERA FRUGIPERDA [PDF]

Mohammed Aly, Heba Fangary, Hasnaa Ibrahim, Sherehan Salem   +3 more
openalex   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Sustained STING-IRF7 signaling aggravates LPS-induced endometrial inflammation via excessive neutrophil extracellular traps generation. [PDF]

Front Immunol
Chu M, Ma D, Song Z, Liang L, Xing F, Bao H.   +5 more
europepmc   +1 more source

Applied Audiology [PDF]

Folia Phoniatrica et Logopaedica, 1996
openaire   +2 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Low-fatigue, adjustable pressure garments at 10, 20 and 30 mm Hg reduce scar thickness and improve pliability. [PDF]

PLoS One
DeBruler DM, Baumann ME, Blackstone BN, Malara MM, Bailey JK, Supp DM, Powell HM.   +6 more
europepmc   +1 more source